SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pharmaids Pharmaceuticals informs about allotment of equity shares

02 Mar 2024 Evaluate
Pharmaids Pharmaceuticals has informed that Board of Directors of the Company at its meeting held on March 02, 2024 approved the allotment of 12856578 fully paid-up Equity Shares for the Consideration other than cash on Preferential Basis by way of Private Placement. The details as required under Regulation 30 of Listing Regulations read with SEBI Circular dated July 13, 2023 are given in the attached intimation.

The above information is a part of company’s filings submitted to BSE.

Pharmaids Pharma Share Price

31.41 0.64 (2.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×